Megan M. Romer

The statistical analysis of monotone incomplete multivariate normal data

Megan M. Romer, 2009 .

The relationship between CAG repeat length and clinical progression in Huntington's disease

Radu Constantinescu, Bernard Ravina, Kevin M. Biglan, 2008, Movement disorders : official journal of the Movement Disorder Society.

Finite-sample inference with monotone incomplete multivariate normal data, III: Hotelling’s T2-statistic

Megan M. Romer, D. Richards, 2013 .

Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease.

Megan M. Romer, K. Kieburtz, L. Rosengren, 2009, Parkinsonism & related disorders.

Increased levels of total tau protein in the cerebrospinal fluid in Huntington's disease.

Megan M. Romer, K. Kieburtz, H. Zetterberg, 2011, Parkinsonism & related disorders.

Malignant melanoma in early Parkinson's disease: The DATATOP trial

Megan M. Romer, K. Kieburtz, R. Constantinescu, 2007, Movement disorders : official journal of the Movement Disorder Society.

Maximum likelihood estimation of the mean of a multivariate normal population with monotone incomplete data

Megan M. Romer, D. Richards, 2010 .

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Jane S. Paulsen, Megan M. Romer, J. Jankovic, 2016, JAMA neurology.

Impact of pramipexole on the onset of levodopa‐related dyskinesias

Megan M. Romer, M. Mcdermott, K. Kieburtz, 2007, Movement disorders : official journal of the Movement Disorder Society.

Kurtosis tests for multivariate normality with monotone incomplete data

Megan M. Romer, D. Richards, Tomoya Yamada, 2014, 1411.7060.

Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease.

Megan M. Romer, K. Kieburtz, L. Rosengren, 2009, Parkinsonism & related disorders.